Terms: = Pancreatic cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
27 results:
1. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
2. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract] [Full Text] [Related]
3. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Leung SS; Borg DJ; McCarthy DA; Boursalian TE; Cracraft J; Zhuang A; Fotheringham AK; Flemming N; Watkins T; Miles JJ; Groop PH; Scheijen JL; Schalkwijk CG; Steptoe RJ; Radford KJ; Knip M; Forbes JM
Diabetes; 2022 Sep; 71(9):1994-2008. PubMed ID: 35713929
[TBL] [Abstract] [Full Text] [Related]
4. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in pancreatic cancer.
Shi X; Yang J; Liu M; Zhang Y; Zhou Z; Luo W; Fung KM; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2022 Jun; 162(7):2004-2017.e2. PubMed ID: 35176309
[TBL] [Abstract] [Full Text] [Related]
5. stat5 promotes chronic pancreatitis by enhancing GM-CSF-dependent neutrophil augmentation.
Lin Y; Chen Y; Feng W; Zhang J; Hua R; Yin B; Yang X
J Leukoc Biol; 2021 Aug; 110(2):293-300. PubMed ID: 34184320
[TBL] [Abstract] [Full Text] [Related]
6. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/stat5 pathway in tumor microenvironment.
Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
[TBL] [Abstract] [Full Text] [Related]
7. Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies.
Menezes JCJMDS; Diederich MF
Pharmacol Res; 2021 May; 167():105525. PubMed ID: 33667686
[TBL] [Abstract] [Full Text] [Related]
8. pancreatic cancer is associated with aberrant monocyte function and successive differentiation into macrophages with inferior anti-tumour characteristics.
Juusola M; Kuuliala K; Kuuliala A; Mustonen H; Vähä-Koskela M; Puolakkainen P; Seppänen H
Pancreatology; 2021 Mar; 21(2):397-405. PubMed ID: 33461933
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
Gitto SB; Beardsley JM; Nakkina SP; Oyer JL; Cline KA; Litherland SA; Copik AJ; Khaled AS; Fanaian N; Arnoletti JP; Altomare DA
Cell Commun Signal; 2020 Jun; 18(1):95. PubMed ID: 32552827
[TBL] [Abstract] [Full Text] [Related]
10. Fibroblasts as a Biological Marker for Curative Resection in pancreatic Ductal Adenocarcinoma.
Katsuta E; Rashid OM; Takabe K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485981
[TBL] [Abstract] [Full Text] [Related]
11. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract] [Full Text] [Related]
12. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer.
Liu Q; Guo L; Zhang S; Wang J; Lin X; Gao F
Mol Med; 2019 Sep; 25(1):44. PubMed ID: 31521106
[TBL] [Abstract] [Full Text] [Related]
13. Prolactin Promotes Fibrosis and pancreatic cancer Progression.
Tandon M; Coudriet GM; Criscimanna A; Socorro M; Eliliwi M; Singhi AD; Cruz-Monserrate Z; Bailey P; Lotze MT; Zeh H; Hu J; Goffin V; Gittes GK; Biankin AV; Esni F
Cancer Res; 2019 Oct; 79(20):5316-5327. PubMed ID: 31395607
[TBL] [Abstract] [Full Text] [Related]
14. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.
Bruno A; Bassani B; D'Urso DG; Pitaku I; Cassinotti E; Pelosi G; Boni L; Dominioni L; Noonan DM; Mortara L; Albini A
FASEB J; 2018 Oct; 32(10):5365-5377. PubMed ID: 29763380
[TBL] [Abstract] [Full Text] [Related]
15. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract] [Full Text] [Related]
16. Suppression of stat5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review.
Yang R; Lu M; Qian X; Chen J; Li L; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2077-86. PubMed ID: 24916170
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
Mace TA; Ameen Z; Collins A; Wojcik S; Mair M; Young GS; Fuchs JR; Eubank TD; Frankel WL; Bekaii-Saab T; Bloomston M; Lesinski GB
Cancer Res; 2013 May; 73(10):3007-18. PubMed ID: 23514705
[TBL] [Abstract] [Full Text] [Related]
19. stat5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.
Moser C; Ruemmele P; Gehmert S; Schenk H; Kreutz MP; Mycielska ME; Hackl C; Kroemer A; Schnitzbauer AA; Stoeltzing O; Schlitt HJ; Geissler EK; Lang SA
Neoplasia; 2012 Oct; 14(10):915-25. PubMed ID: 23097626
[TBL] [Abstract] [Full Text] [Related]
20. A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.
Zhao W; Jaganathan S; Turkson J
J Biol Chem; 2010 Nov; 285(46):35855-65. PubMed ID: 20807764
[TBL] [Abstract] [Full Text] [Related]
[Next]
